Search clinical trials for: Antigens, CD20
Total 550 results
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon-hodgkin's LymphomaChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; University of Rochester and other collaboratorsCompletedNon-Hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityEnrolling by invitationRelapsed or Refractory B-cell Non-Hodgkin LymphomaChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | CD20 PositiveUnited States
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Mario Negri Institute for Pharmacological ResearchRecruiting
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of
-
Copenhagen University Hospital at HerlevCompletedPrednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic AnemiaAnemia, Hemolytic, AutoimmuneDenmark
-
Han weidongRecruitingRelapsed and Refractory B-cell Non-Hodgkin's Lymphoma | Decitabine-primed Tandem CD19/CD20 CAR T CellsChina
-
Weill Medical College of Cornell UniversityCompleted
-
University of LiverpoolGlaxoSmithKline; Chugai Pharma USA; Napp Pharmaceuticals LimitedUnknownChronic Lymphocytic LeukaemiaUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in Pediatric...CompletedKidney Transplant | Kidney Transplant Recipient | Graft Function/Survival | de Novo HLA Antibodies DevelopmentUnited States
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
Puyang Oilfield General HospitalNot yet recruiting
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | B-Cell Lymphoma | Chronic Lymphocytic LymphomaUnited States
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
Lymphoma Study AssociationAmgenCompletedUntreated CD20-positive Large B-cell LymphomaFrance
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Non-Hodgkin's LymphomaHong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
-
Joseph TuscanoNational Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSTerminatedCD20 Positive Diffuse Large B-cell Lymphoma | Elderly Unfit PatientsItaly
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
Peking Union Medical College HospitalCompletedAutoimmune Hemolytic Anemia | Autoimmune Hemolytic Anemia and Autoimmune ThrombocytopeniaChina
-
Haukeland University HospitalCompletedChronic Fatigue Syndrome | Myalgic EncephalomyelitisNorway
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
University Hospital, GhentCompletedEarly and Severe Systemic SclerosisBelgium
-
PrECOG, LLC.Genentech, Inc.TerminatedIndolent Non-Hodgkin's LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingBurkitt Lymphoma | Primary Mediastinal Large B-cell Lymphoma | Gray Zone Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Anaplastic Large-Cell LymphomaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownDiffuse Large B-cell LymphomaChina
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Emory UniversityNational Cancer Institute (NCI); AstraZenecaRecruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Lymphoproliferative Disorder | Indolent Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Universität des SaarlandesSpectrum Pharmaceuticals, Inc; German High-Grade Non-Hodgkin's Lymphoma Study...CompletedCD20+ Aggressive B-Cell LymphomaGermany
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Qiu LuguiNanjing Legend Biotech Co.RecruitingB-cell Lymphoma Refractory | B-cell Lymphoma RecurrentChina
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedNon-Hodgkin's Lymphoma (NHL)United States
-
Zhujiang HospitalNanfang Hospital, Southern Medical UniversityRecruitingTherapy Related LeukemiaChina
-
Institute of Hematology & Blood Diseases Hospital...Henan Cancer Hospital; Beijing Children's Hospital; Tianjin Medical University... and other collaboratorsRecruitingPrimary Immune Thrombocytopenia (ITP)China
-
University of BernHoffmann-La Roche; Swiss National Science FoundationCompleted
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals,...TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
Centre de Recherches et d'Etude sur la Pathologie...Completed
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited States
-
Januario Castro, M.D.GlaxoSmithKlineCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
Lymphoma Study AssociationTerminatedCD20-Positive Large B-Cell LymphomaFrance
-
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)RecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | MALT Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Indolent Lymphoma | Refractory B-Cell LymphomaUnited States, Australia, China